Hyaluronic Acid Viscosupplementation Market: By Course of Treatment; By Osteoarthritis - Forecast 2016-2021

  • ID: 3339512
  • Report
  • 180 pages
  • IndustryARC
1 of 3
Osteoarthritis of the knee is the key cause of disability among the people. This degenerative joint disease is caused due to wear and tear of joint’s cartilage. Joint injuries, obesity and genetic problem are other cause of osteoarthritis. Viscosupplementation is one of the treatment procedures to relief Osteoarthritis. In this procedure a thick fluid called hyaluronic acid is directly injected into knee joint. The hyaluronic acid is found in synovial fluid surrounding joints that act as lubricating agent enabling smooth movement of bones. This gel-like fluid also acts as shock absorber for joint loads. This procedure helps to improve the mobility of the joints and assures more comfort level during any activity.

In this report, Global Hyaluronic Acid Viscosupplementation Market is segmented by course of Treatment and Anatomy. The treatment of Osteoarthritis can be done by Single Injection or Multiple Injections of hyaluronic acid into the joints. The market on basis of anatomy can be divided by Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis and Shoulder Osteoarthritis.

The market is also analyzed based on geographic regions which are grouped into Americas, Asia-Pacific (APAC), Europe as well as RoW regions. Osteoarthritis constitutes to be a growing public health problem. This disease is commonly found among adults in the U.S. Thus, the U.S. is leading in providing viscosupplementation treatment. In APAC, the market is forecast to grow since some countries like India possess high number of knee-osteoarthritis patients. Europe is the next leading region for this market. Since, there are no reimbursements in European countries such as Spain, France and other countries; the market in this region is still low.

The major companies of Hyaluronic Acid Viscosupplementation Market are:
Sanofi (France),
Fidia Pharma USA Inc. (U.S),
Ferring Pharmaceuticals Inc. (Switzerland),
Mylan Inc. (U.S),
Zimmer Inc. (U.S.) and many others.

The data is obtained by help of primary and secondary sources. Many questionnaires and interviews were conducted with the key companies of this market to estimate the market values. Secondary sources such as articles and medical journals were study to have an overview of the market. Public health data has been collected from some organization such as World Health Organization that helped to analyze the entire market.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Hyaluronic Acid Viscosupplementation Market Overview

2. Executive Summary

3. Hyaluronic Acid Viscosupplementation Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis

4. Hyaluronic Acid Viscosupplementation Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Hyaluronic Acid Viscosupplementation Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Life Cycle Analysis
5.4. Pricing Analysis

6. Hyaluronic Acid Viscosupplementation Market- By Course of Treatment
6.1. By Single Injection
6.2. By Multiple Injections

7. Hyaluronic Acid Viscosupplementation Market- By Anatomy
7.1. Knee Osteoarthritis
7.2. Hip Osteoarthritis
7.3. Ankle Ostereoarthritis
7.4. Shoulder Osteoarthritis

8. Hyaluronic Acid Viscosupplementation Market- Geographic Analysis
8.1. Introduction
8.2. Americas
8.2.1. Canada
8.2.2. US
8.2.3. Brazil
8.2.4. Others
8.3. Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Spain
8.3.5. Netherland
8.3.6. Others
8.4. APAC
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Others
8.5. ROW

9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships

10. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio)
10.1. Euflexxa
10.2. Fidia Farma USA Inc.
10.3. Anika Therapeutics, Inc.
10.4. Synvisc –One
10.5. Supartz
10.6. Zimmer, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown